Product Information
MORPHINE SULF ER 30 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.4334 per EA under NDC 00228427111. Its NADAC has been published 560 times since Nov 11, 2015.
FDA first approved this application on Apr 6, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Morphine sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228427111
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
MORPHINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA203849FDA Approved
4/6/2015
TE Code
AB
On Market Since
10/26/2015
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE SULF ER 30 MG TABLET has been published 560 times since Nov 11, 2015, and over the history we have for it it has declined 42.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4334 per EA |
|---|---|
| All-time high | $0.7674 (Jan 13, 2016) |
| All-time low | $0.2713 (Nov 20, 2019) |
| 52-week high | $0.4336 |
| 52-week low | $0.3632 |
| Median price | $0.3654 |
| Average price | $0.4000 |
| Largest weekly change | +27.0% (Jan 22, 2020) |
| Weeks tracked | 560 |
| Tracking since | Nov 11, 2015 |
1W
N/A
1M
0.0%
3M
+7.3%
6M
+19.0%
1Y
+0.9%
3Y
+25.8%
5Y
+28.1%
All
-42.7%
Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Morphine sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MORPHINE SULF ER 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULF ER 30 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.4334 per EA (NDC 00228427111), effective Jul 29, 2026.
How has the price of MORPHINE SULF ER 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for MORPHINE SULF ER 30 MG TABLET has declined 42.7%. It has been tracked across 560 weekly CMS publications since Nov 11, 2015.
What are the highest and lowest recorded NADAC prices for MORPHINE SULF ER 30 MG TABLET?
Since Nov 11, 2015, the NADAC for MORPHINE SULF ER 30 MG TABLET has ranged from a low of $0.2713 (Nov 20, 2019) to a high of $0.7674 (Jan 13, 2016), with a median of $0.3654 per EA.
Are there cheaper alternatives to MORPHINE SULF ER 30 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of MORPHINE SULF ER 30 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MORPHINE SULF ER 30 MG TABLET?
MORPHINE SULF ER 30 MG TABLET (NDC 00228427111) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.